secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2023-10-31T23:59:59+00:00
Accession:  0001005286-23-000118
Event type: other_material
Sentiment:  negative
Materiality: 0.78
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical restating FY21, FY22 financials for errors in interest, inventory, and divestitures
--------------------------------------------------------------------------------

- Audit committee concludes prior financials for FY21, FY22, and interim periods 2020-2023 should no longer be relied upon.
- Errors involve capitalized interest calculation, inventory valuation, and adjustments related to former Curation Foods segment.
- Material weaknesses in internal control over financial reporting identified as of May 29, 2022.
- Restatement expected to impact FY23 earnings release; company expects no adverse effect on operations or liquidity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000118/0001005286-23-000118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000118/lndc-20231030.htm
  HTML page:      https://secwatch.observer/filing/0001005286-23-000118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer